Ultragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Update
Go back to Ultragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Update| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 28.68 +1.24 (4.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.44 | 52 Week High | $117.12 | |||
| Open | $27.56 | 52 Week Low | $46.52 | |||
| Day High | $28.77 | P/E | N/A | |||
| Day Low | $27.49 | EPS | $-1.97 | |||
| Volume | 749,075 | |||||
